ES2039204T3 - Complejos de 1,2-diaminociclohexano platino, solubles, estables. - Google Patents

Complejos de 1,2-diaminociclohexano platino, solubles, estables.

Info

Publication number
ES2039204T3
ES2039204T3 ES198686310170T ES86310170T ES2039204T3 ES 2039204 T3 ES2039204 T3 ES 2039204T3 ES 198686310170 T ES198686310170 T ES 198686310170T ES 86310170 T ES86310170 T ES 86310170T ES 2039204 T3 ES2039204 T3 ES 2039204T3
Authority
ES
Spain
Prior art keywords
soluble
stable
platinum
diaminociclohexane
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198686310170T
Other languages
English (en)
Spanish (es)
Inventor
Paul Schwartz
Devinder Singh Gill
Kenneth James Mcgrath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Andrulis Research Corp
Original Assignee
Andrulis Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andrulis Research Corp filed Critical Andrulis Research Corp
Application granted granted Critical
Publication of ES2039204T3 publication Critical patent/ES2039204T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES198686310170T 1985-12-26 1986-12-29 Complejos de 1,2-diaminociclohexano platino, solubles, estables. Expired - Lifetime ES2039204T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/813,451 US4680308A (en) 1985-12-26 1985-12-26 Stable soluble 1,2-diaminocyclohexane platinum complexes

Publications (1)

Publication Number Publication Date
ES2039204T3 true ES2039204T3 (es) 1993-09-16

Family

ID=25212407

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198686310170T Expired - Lifetime ES2039204T3 (es) 1985-12-26 1986-12-29 Complejos de 1,2-diaminociclohexano platino, solubles, estables.

Country Status (12)

Country Link
US (1) US4680308A (enExample)
EP (1) EP0228298B1 (enExample)
JP (1) JPH0717666B2 (enExample)
AT (1) ATE73813T1 (enExample)
AU (1) AU594099B2 (enExample)
CA (1) CA1261863A (enExample)
DE (1) DE3684435D1 (enExample)
ES (1) ES2039204T3 (enExample)
GR (1) GR3004970T3 (enExample)
IE (1) IE59692B1 (enExample)
IL (1) IL80620A (enExample)
ZA (1) ZA869649B (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5384127A (en) * 1985-10-18 1995-01-24 Board Of Regents, The University Of Texas System Stable liposomal formulations of lipophilic platinum compounds
US5117022A (en) * 1985-10-18 1992-05-26 The Board Of Regents, The University Of Texas System Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
US5041581A (en) * 1985-10-18 1991-08-20 The University Of Texas System Board Of Regents Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
US5011959A (en) * 1986-11-17 1991-04-30 The Board Of Regents, The University Of Texas System 1,2-diaminocyclohexane-platinum complexes with antitumor activity
US4808730A (en) * 1987-06-23 1989-02-28 American Cyanamid Company Synthesis of cisplatin analogs
US4904809A (en) * 1987-09-25 1990-02-27 Ss Pharmaceutical Co., Ltd. Platinum complex
US4931553A (en) * 1988-05-11 1990-06-05 Gill Devinder S Platinum-polymer complexes and their use as antitumor agents
US5035878A (en) * 1988-09-12 1991-07-30 University Of Rochester Use of dithiocarbamates to counteract myelosuppression
US5294430A (en) * 1988-09-12 1994-03-15 University Of Rochester Use of dithiocarbamates to treat myelosuppression
US5187193A (en) * 1988-09-12 1993-02-16 University Of Rochester Method for stimulating transplanted bone marrow cells
US5434256A (en) * 1988-11-22 1995-07-18 Board Of Regents, The University Of Texas System Diamine platinum complexes as antitumor agents
US5393909A (en) * 1988-11-22 1995-02-28 Board Of Regents, The University Of Texas System Diamine platinum complexes as antitumor agents
US5041578A (en) * 1988-11-22 1991-08-20 Board Of Regents, The University Of Texas System Water soluble 1,2-diaminocyclohexane platinum (IV) complexes as antitumor agents
JP3154399B2 (ja) * 1996-07-04 2001-04-09 デビオファーム エス．アー． 白金化合物の製造方法
AU2003239511A1 (en) * 2003-05-20 2004-12-13 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising a liposomal platinum complex
CN102603805A (zh) * 2012-02-14 2012-07-25 昆明贵研药业有限公司 具有抗肿瘤活性的铂（ii）配合物及其制备方法
US9768463B2 (en) 2012-07-27 2017-09-19 Lockheed Martin Advanced Energy Storage, Llc Aqueous redox flow batteries comprising metal ligand coordination compounds
US10164284B2 (en) 2012-07-27 2018-12-25 Lockheed Martin Energy, Llc Aqueous redox flow batteries featuring improved cell design characteristics
US9382274B2 (en) * 2012-07-27 2016-07-05 Lockheed Martin Advanced Energy Storage, Llc Aqueous redox flow batteries featuring improved cell design characteristics
EP3224266B1 (en) 2014-11-26 2021-03-03 Lockheed Martin Energy, LLC Metal complexes of substituted catecholates and redox flow batteries containing the same
US10253051B2 (en) 2015-03-16 2019-04-09 Lockheed Martin Energy, Llc Preparation of titanium catecholate complexes in aqueous solution using titanium tetrachloride or titanium oxychloride
US10644342B2 (en) 2016-03-03 2020-05-05 Lockheed Martin Energy, Llc Coordination complexes containing monosulfonated catecholate ligands and methods for producing the same
US10316047B2 (en) 2016-03-03 2019-06-11 Lockheed Martin Energy, Llc Processes for forming coordination complexes containing monosulfonated catecholate ligands
US9938308B2 (en) 2016-04-07 2018-04-10 Lockheed Martin Energy, Llc Coordination compounds having redox non-innocent ligands and flow batteries containing the same
US10343964B2 (en) 2016-07-26 2019-07-09 Lockheed Martin Energy, Llc Processes for forming titanium catechol complexes
US10377687B2 (en) 2016-07-26 2019-08-13 Lockheed Martin Energy, Llc Processes for forming titanium catechol complexes
US10065977B2 (en) 2016-10-19 2018-09-04 Lockheed Martin Advanced Energy Storage, Llc Concerted processes for forming 1,2,4-trihydroxybenzene from hydroquinone
US10930937B2 (en) 2016-11-23 2021-02-23 Lockheed Martin Energy, Llc Flow batteries incorporating active materials containing doubly bridged aromatic groups
US10497958B2 (en) 2016-12-14 2019-12-03 Lockheed Martin Energy, Llc Coordinatively unsaturated titanium catecholate complexes and processes associated therewith
US10741864B2 (en) 2016-12-30 2020-08-11 Lockheed Martin Energy, Llc Aqueous methods for forming titanium catecholate complexes and associated compositions
US10320023B2 (en) 2017-02-16 2019-06-11 Lockheed Martin Energy, Llc Neat methods for forming titanium catecholate complexes and associated compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2166076A (en) * 1936-02-27 1939-07-11 Baker & Co Inc Platinum metal compounds and methods of making them
US4044034A (en) * 1975-07-22 1977-08-23 The Miranol Chemical Company, Inc. Nitrogenous condensation products
US4115418A (en) * 1976-09-02 1978-09-19 Government Of The United States Of America 1,2-diaminocyclohexane platinum (ii) complexes having antineoplastic activity
US4137248A (en) * 1977-08-29 1979-01-30 The United States Of America As Represented By The Department Of Health, Education And Welfare Compound, 4-carboxyphthalato(1,2-diaminocyclohexane)-platinum(II) and alkali metal salts thereof
JPS5829957B2 (ja) * 1977-09-12 1983-06-25 喜徳 喜谷 新規な白金錯体
JPS5472780A (en) * 1977-11-22 1979-06-11 Fuji Photo Film Co Ltd Stabilizing method for organic basic substance to light
JPS59112995A (ja) * 1982-12-21 1984-06-29 Shionogi & Co Ltd 新規グリコ−ル酸白金錯体
US4565884A (en) * 1983-05-10 1986-01-21 Andrulis Research Corporation Bis-platinum complexes as antitumor agents
IL71804A (en) * 1983-05-10 1989-06-30 Andrulis Res Corp Bis-(platinum diamine)complexes and antitumor pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
GR3004970T3 (enExample) 1993-04-28
ZA869649B (en) 1987-08-26
US4680308A (en) 1987-07-14
EP0228298A2 (en) 1987-07-08
IE862951L (en) 1987-06-26
IL80620A0 (en) 1987-02-27
AU594099B2 (en) 1990-03-01
JPH0717666B2 (ja) 1995-03-01
EP0228298B1 (en) 1992-03-18
JPS62158297A (ja) 1987-07-14
DE3684435D1 (de) 1992-04-23
EP0228298A3 (en) 1987-12-02
ATE73813T1 (de) 1992-04-15
AU6574886A (en) 1987-07-02
IE59692B1 (en) 1994-03-23
CA1261863A (en) 1989-09-26
IL80620A (en) 1990-12-23

Similar Documents

Publication Publication Date Title
ATE73813T1 (de) Stabile und loesliche 1,2-diamino-cyclohexanplatin-komplexe.
NO890075L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazoler.
NL300136I2 (nl) Farmacologisch actieve catecholderivaten en samenstellingen ervan.
NO863061D0 (no) Fremgangsmaate for fremstilling av fysiologisk aktive fenoksyeddiksyrederivater.
NO863671L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-2-heterocykloalkylpyrido(4,3)indoler.
IT8820550A0 (it) Benzammidi sostituite farmacologicamente attive.
FR2581543B1 (fr) Pharmacotechnie permettant la realisation d'une preparation insulinique active par voie orale
DK165966C (da) Forbedret piroxicamholdigt anti-inflammatorisk praeparat
IL76345A0 (en) Proline derivatives and antihypertensive and anti-glaucoma pharmaceutical preparations containing the same
FI893212L (fi) Antihypertensiva aminoalkylaminokarbo- nylaminodiolaminsyraderivat.
NO862390D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater.
DE3674043D1 (de) Pharmakologisch aktive mitomycinderivate.
NO893768L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2,7-diamino-1,2,3,4-tetrahydronaftalenderivater.
NO882256D0 (no) Fremgangsmaate for fremstilling av farmakologisk aktive kinolinforbindelser.
DE68908838D1 (de) Pharmazeutisch wirksame Dithioketen-Derivaten.
DE3778133D1 (de) Mitomycinderivate.
NO862648L (no) Framgangsmÿte for framstilling av farmakologisk aktive 2-substituerte-3,4-dihydroksyfenyletylamino-derivater.
AU476756B2 (en) PHARMACOLOGICALLY ACTIVE 4, 8-DIMETHOXY-FURO-(3',2'-F) BENZOXAZOL-2-yl ACETHYDROXAMIC ACID
ATE75725T1 (de) Derivate von vorstufen von carboxylsaeuremedikamenten.
NO165798C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-disubstituerte 2-oksindol-derivater.
IT8619120A0 (it) Propandiolo derivati farmacologicamente attivi.
DK163661C (da) 2,5-pyrrolidindionderivater og farmaceutisk acceptable syreadditionssalte deraf
NO164657C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,8-nafthyridinoner.
IT8622433A0 (it) Piridotienodiazepin derivati farmacologicamente attivi.
IT8721769A0 (it) Tioderivati beta-lattamici farmacologicamente attivi eprocedimento per la loro preparazione.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 228298

Country of ref document: ES